Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi H, Fukutomi Y, Mitsui C, Kajiwara K, Watai K, Tomita Y, Kamide Y, Tsuburai T, Sekiya K, Ishii M, Hasegawa Y, Taniguchi M. Hayashi H, et al. Among authors: tsuburai t. J Allergy Clin Immunol. 2023 Jun;151(6):1667-1672.e2. doi: 10.1016/j.jaci.2023.03.014. Epub 2023 Mar 24. J Allergy Clin Immunol. 2023. PMID: 36967017 Free article. Clinical Trial.
Relationship between exhaled nitric oxide measured by two offline methods and bronchial hyperresponsiveness in Japanese adults with asthma.
Tsuburai T, Tsurikisawa N, Morita S, Hasunuma H, Kanegae H, Ishimaru Y, Fukutomi Y, Tanimoto H, Ono E, Oshikata C, Sekiya K, Otomo M, Maeda Y, Taniguchi M, Ikehara K, Akiyama K. Tsuburai T, et al. Allergol Int. 2008 Sep;57(3):223-9. doi: 10.2332/allergolint.O-07-518. Epub 2008 Jun 1. Allergol Int. 2008. PMID: 18493167 Free article.
113 results